| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 49.069 | 67.455 | 110.282 | 104.042 |
| Total Income - EUR | - | - | - | - | - | - | 49.069 | 67.457 | 110.284 | 104.044 |
| Total Expenses - EUR | - | - | - | - | - | - | 34.270 | 42.616 | 54.243 | 60.791 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 14.799 | 24.841 | 56.041 | 43.253 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 14.309 | 24.180 | 54.960 | 40.194 |
| Employees | - | - | - | - | - | - | 2 | 2 | 2 | 3 |
Check the financial reports for the company - Em Morosan Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 19.089 | 17.362 | 13.773 | 14.200 |
| Current Assets | - | - | - | - | - | - | 5.176 | 19.688 | 46.062 | 26.452 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 115 | 18.033 | 33.888 | 19.454 |
| Cash | - | - | - | - | - | - | 5.061 | 1.655 | 12.174 | 6.998 |
| Shareholders Funds | - | - | - | - | - | - | 14.349 | 24.220 | 55.001 | 34.741 |
| Social Capital | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Debts | - | - | - | - | - | - | 10.143 | 12.830 | 5.063 | 6.330 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Em Morosan Med S.r.l.